TrialNeurogenetics2025
Miglustat does not impact clinical progression in patients with spastic paraplegia type 11.
Serena Mero et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
TrialNeurogenetics2025
Serena Mero et al.PubMed ↗Publisher ↗
No numbers read from the abstract.